Immune restoration following hematopoietic stem cell transplantation: an evolving target (Q36075296)

12 August 2017

1 reference

title

Immune restoration following hematopoietic stem cell transplantation: an evolving target (English)

1 reference

12 August 2017

Auletta JJ

1

1 reference

PubMed ID

15778723

12 August 2017

Lazarus HM

series ordinal

2

1 reference

PubMed ID

15778723

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Bone Marrow Transplantation

12 August 2017

1 reference

12 August 2017

35

1 reference

12 August 2017

9

1 reference

12 August 2017

835-857

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704966

12 August 2017

0 references

cites work

The immune system. First of two parts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The immune system. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Heterologous cells cooperate to augment stem cell migration, homing, and engraftment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Regulation of hematopoietic stem cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Differentiation plasticity of hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The biology of human natural killer-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Innate immunity via Toll-like receptors and Nod proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The interface between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Regulation of interferon-gamma production by IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Recognition of tumor cells by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunogenetics of killer-cell immunoglobulin-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interplay of natural killer cells and their receptors with the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immune regulation by regulatory T cells: implications for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Visualizing dendritic cell networks in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immune reconstitution following allogeneic peripheral blood stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

On guard--activating NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunological reconstitution following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Vaccination against infectious disease following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Infections in recipients of blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The pathophysiology of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The Pathophysiology of Acute Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Type 1/Type 2 immunity in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Evolving strategies to address adverse transplant outcomes associated with T cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Genetically haploidentical stem cell transplantation for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Developmental pharmacology--drug disposition, action, and therapy in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Manipulating dendritic cell biology for the active immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Graft-versus-leukemia reactions in allogeneic chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Heat shock protein 70: role in antigen presentation and immune stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Ex vivo expansion of natural killer cells for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Strategies to improve dendritic cell-based immunotherapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Antigen-induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mesenchymal stem cells: biology and potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Monoclonal antibodies as therapeutic agents for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The role of monoclonal antibodies in stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The whys and hows of hematopoietic progenitor and stem cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin-18 regulates both Th1 and Th2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Natural killer lymphocytes: biology, development, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interleukin-7: from bench to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Therapeutics targeting the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Toll-like receptors stimulate human neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Monoclonal antibodies for the prevention and treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Chemokines and cell migration in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

The biology of chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Distinct patterns and kinetics of chemokine production regulate dendritic cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Chemokines: agents for the immunotherapy of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Danger signals: SOS to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Roles of heat-shock proteins in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Spinning molecular immunology into successful immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Deactivation of the innate cellular immune response following endotoxic and surgical injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Endotoxin tolerance: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Dendritic cells giveth and taketh away

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

T-Cell recovery in adults and children following umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Immunological aspects of haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Dendritic cell recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Monocytes from mobilized stem cells inhibit T cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Immune reconstitution after autologous purged bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Mechanisms of immune dysfunction in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Adoptive immunotherapy for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Ex vivo purging of allogeneic marrow with L-Leucyl-L-leucine methyl ester. A phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

FLT3: receptor and ligand. Biology and potential clinical application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Enhanced susceptibility to apoptosis in T cells recovering after autologous peripheral blood progenitor cell transplantation: reversal by interleukin-15

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Interleukin 7 worsens graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704966

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704966

1 reference

12 August 2017

1 reference

PubMed ID

15778723